A Study Pilot About the Contribution of Pleuropulmonary Echography Iin Acute Bronchiolitis Among Infants (ECHOPE)
Primary Purpose
Bronchiolitis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Pleuropulmonary echography
Sponsored by
About this trial
This is an interventional diagnostic trial for Bronchiolitis
Eligibility Criteria
Inclusion Criteria:
- Infants aged <= 2 years old
- Medical diagnosis of acute bronchiolitis requiring hospitalization in the pediatric departments of the Besançon University Hospital
- No opposition from the parents for performing the pleuropulmonary echography.
Exclusion Criteria:
- Children aged > 2 years old
- Infants aged < 2 years old consultant in pediatric emergencies for acute bronchiolitis without subsequent hospitalization.
- Previous chronic lung disease (including pulmonary bronchodysplasia), unoperated congenital heart disease or neuromuscular disease.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pleuropulmonary echography
Arm Description
Outcomes
Primary Outcome Measures
Comparison between PleuroPulmonary Echography [PPE] and pulmonary radiography
Comparative analysis between PPE and chest/pulmonary radiography (gold standard) for the diagnosis of bacterial pneumonitis associated with acute bronchiolitis in infants.
Secondary Outcome Measures
Full Information
NCT ID
NCT04935996
First Posted
June 15, 2021
Last Updated
June 15, 2021
Sponsor
Centre Hospitalier Universitaire de Besancon
1. Study Identification
Unique Protocol Identification Number
NCT04935996
Brief Title
A Study Pilot About the Contribution of Pleuropulmonary Echography Iin Acute Bronchiolitis Among Infants
Acronym
ECHOPE
Official Title
A Study Pilot About the Contribution of Pleuropulmonary Echography Iin Acute Bronchiolitis Among Infants
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
June 2021 (Anticipated)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pleuropulmonary echography remains an almost non-existent tool in routine pediatric practice.
Our study is part of a desire to develop its use in pediatrics, in particular for the diagnosis of acute bacterial pneumonitis associated with acute bronchiolitis among infants.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bronchiolitis
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pleuropulmonary echography
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Pleuropulmonary echography
Intervention Description
Pleuropulmonary echography is performed, in addition of the chest X-ray already performed in routine care
Primary Outcome Measure Information:
Title
Comparison between PleuroPulmonary Echography [PPE] and pulmonary radiography
Description
Comparative analysis between PPE and chest/pulmonary radiography (gold standard) for the diagnosis of bacterial pneumonitis associated with acute bronchiolitis in infants.
Time Frame
Day 1
10. Eligibility
Sex
All
Maximum Age & Unit of Time
2 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infants aged <= 2 years old
Medical diagnosis of acute bronchiolitis requiring hospitalization in the pediatric departments of the Besançon University Hospital
No opposition from the parents for performing the pleuropulmonary echography.
Exclusion Criteria:
Children aged > 2 years old
Infants aged < 2 years old consultant in pediatric emergencies for acute bronchiolitis without subsequent hospitalization.
Previous chronic lung disease (including pulmonary bronchodysplasia), unoperated congenital heart disease or neuromuscular disease.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Julien BEHR, MD
Phone
0033381667400
Email
jbehr@chu-besancon.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julien BEHR, MD
Organizational Affiliation
CHU de Besançon
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Study Pilot About the Contribution of Pleuropulmonary Echography Iin Acute Bronchiolitis Among Infants
We'll reach out to this number within 24 hrs